Item 5.07 Submission of Matters to a Vote of Security Holders.

At the annual meeting of stockholders of Helius Medical Technologies, Inc. (the "Company") held on May 23, 2022, the Company's stockholders: (i) elected six directors, each to serve for a one-year term until the 2023 annual meeting of stockholders or until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal; (ii) ratified the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022; and (iii) approved the Helius Medical Technologies, Inc. 2022 Equity Incentive Plan.

The 2022 Equity Incentive Plan of the Company is a comprehensive equity based plan that provides for the grants of various stock awards including incentive and nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, and other stock awards, which can be awarded to employees and directors of the Company and its subsidiaries. The foregoing description of the 2022 Equity Incentive Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Proposal 1-Election of directors:



Nominee              Votes For      Votes Withheld       Broker Non-Votes
Blane Walter          1,498,627           33,616               851,866
Dane C. Andreeff      1,498,354           33,889               851,866
Edward M. Straw       1,406,469           125,774              851,866
Jeffrey Mathiesen     1,521,247           10,996               851,866
Paul Buckman          1,470,793           61,450               851,866
Sherrie Perkins       1,420,724           111,519              851,866

Proposal 2-Ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022:



Votes For      Votes Against       Abstain
2,372,036           12,071              2



Proposal 3-Approval of the Helius Medical Technologies, Inc. 2022 Equity
Incentive Plan:

                                                 Broker
Votes For      Votes Against      Abstain      Non-Votes
1,096,651          427,112           8,480        851,866

Item 9.01 Financial Statements and Exhibits.





 (d) Exhibits

Exhibit No.   Description

   10.1       Helius Medical Technologies, Inc. 2022 Equity Incentive Plan,
              effective as of May 23, 2022 (  incorporated by reference to Exhibit
              10.1 to the Form 8-K filed on February 18, 2022  )
    104       Cover Page Interactive Data File (embedded within Inline XBRL
              document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses